Miquel Duran-Frigola

Miquel is the Chief Scientific Officer and Co-Founder at Ersilia. His research interests lie at the intersection between drug discovery and large-scale biological data analysis. He has held positions at IRB Barcelona, the Massachusetts Institute of Technology (MIT), Tel Aviv University, ISGlobal-CISM (Mozambique), and CIDRZ (Zambia). He holds an MSc in Bioinformatics and a PhD in Biomedicine from Pompeu Fabra University, as well as a BSc in Chemistry from Ramon Llull University.